Use our new account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

mifepristone

mifepristone

6 results

Filter Results By

Filter Applied. Clear All

Latest Posts

June 2, 2023 Abortion Reporting: New York City (2020) Abortion Reporting: New York City (2020) June 2, 2023 Abortion Reporting: Iowa (2021) Abortion Reporting: Iowa (2021) May 31, 2023 Expanding State and Federal Support for Decisions for Life Expanding State and Federal Support for Decisions for Life
Reset All Filters
6 results
mifepristone

Lozier Institute Statement on Abortion Pill Lawsuit Filed by Alliance Defending Freedom

Charlotte Lozier Institute, which in 2021 revealed a dramatic surge in abortion pill-related emergency room visits, today applauded Alliance Defending Freedom for challenging the U.S. Food and Drug Administration’s (FDA) erroneous and highly-politicized approval of the abortion drug regimen.

charlotte-lozier-institute Charlotte Lozier Institute
November 18, 2022
mifepristone

Dangerous Deception: Not Telling Your Doctor About Abortion Pill Use Increases Health Risks

A new analysis of 423,000 confirmed abortions debunks the common abortion industry narrative that “there’s no medical reason to tell a doctor about an abortion.”

mifepristone

Public Health Threat: Connecticut DPH Data Shows More Women Using Risky Abortion Method

Half of all Connecticut abortions are performed with potentially dangerous drugs which multiple peer-reviewed studies have linked to higher rates of complications.

mifepristone

Public Health Threat: Chemical Abortion Leads to Significantly Higher Rate of ER Visits

As the Food and Drug Administration (FDA) works toward a December 16 decision on chemical abortion safeguards, a groundbreaking new study from Charlotte Lozier Institute (CLI) shows that increased access to abortion pills creates a significant public health risk.

featured-image
mifepristone

Issues in Law and Medicine Spring 2017 Summaries

mifepristone

Abortion Increases Risk of Preterm Birth: More Evidence in New Publication

The recent systematic review published by Gabrielle Saccone and colleagues joins the long list of over 150 studies over the

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image